Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment using activatable anti-EGFR antibodies

Methods of treatment using activatable anti-EGFR antibodies

US Patent 10875913 · Granted Dec 29, 2020

Estimated economic value: $5,967,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Anti-C1S antibodies and methods of use thereof2025
Gene-edited natural killer cells2025
T-cells expressing anti-LIV1 chimeric antigen receptor2025
Quality control reagents and methods for serum antibody profiling2025
Quality control reagents and methods for serum antibody profiling2025
Methods and compositions for assessing antibody specificities2025
Methods and compositions for assessing antibody specificities2025
Anti-complement C1s antibodies and uses thereof2025
Anti-complement C1s antibodies and uses thereof2025
Activatable anti-VEGF scFv2025